Holders over time
- CHE
- ELV
| Quarter | CHE | ELV |
|---|---|---|
| Q3 2020 | 16 holders, $1.0bn | 30 holders, $15.0bn |
| Q4 2020 | 14 holders, $1.1bn | 29 holders, $16.7bn |
| Q1 2021 | 13 holders, $898m | 25 holders, $18.6bn |
| Q2 2021 | 13 holders, $920m | 30 holders, $19.4bn |
| Q3 2021 | 13 holders, $1.0bn | 26 holders, $18.5bn |
| Q4 2021 | 13 holders, $1.1bn | 29 holders, $23.3bn |
| Q1 2022 | 12 holders, $906m | 31 holders, $23.9bn |
| Q2 2022 | 12 holders, $798m | 32 holders, $23.3bn |
| Q3 2022 | 12 holders, $664m | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $834m | 34 holders, $25.5bn |
| Q1 2023 | 13 holders, $855m | 39 holders, $22.5bn |
| Q2 2023 | 13 holders, $961m | 38 holders, $20.6bn |
| Q3 2023 | 16 holders, $982m | 34 holders, $19.8bn |
| Q4 2023 | 13 holders, $1.1bn | 36 holders, $20.3bn |
| Q1 2024 | 12 holders, $1.1bn | 35 holders, $21.3bn |
| Q2 2024 | 14 holders, $912m | 33 holders, $22.1bn |
| Q3 2024 | 13 holders, $693m | 30 holders, $20.2bn |
| Q4 2024 | 11 holders, $588m | 32 holders, $15.9bn |
| Q1 2025 | 12 holders, $657m | 28 holders, $17.1bn |
| Q2 2025 | 11 holders, $582m | 27 holders, $14.8bn |
| Q3 2025 | 8 holders, $487m | 27 holders, $12.7bn |
| Q4 2025 | 13 holders, $634m | 25 holders, $17.0bn |
| Q1 2026 | 12 holders, $612m | 26 holders, $13.6bn |
| Q2 2026 | 10 holders, $807m | 28 holders, $17.7bn |
Chemed Corp New
- Holders
- 13
- Reported value
- $1.1bn
- Buyers
- 5
- Sellers
- 7
Breadth -2 among 93 comparable managers.
Elevance Health Inc Formerly
- Holders
- 36
- Reported value
- $20.3bn
- Buyers
- 10
- Sellers
- 27
Breadth -17 among 93 comparable managers.
Who holds both, Q4 2023
Both (8)
Acadian Asset Management LLC, AQR Capital Management LLC, Bridgewater Associates LP, MFS Investment Management, Neuberger Berman Group LLC, Renaissance Technologies LLC, Two Sigma Investments LP, Wellington Management Group LLP
Only CHE (5)
Capital World Investors, Durable Capital Partners LP, Farallon Capital Management LLC, GAMCO Investors Inc, Holocene Advisors LP
Only ELV (28)
AllianceBernstein LP, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Citadel Advisors LLC, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, Millennium Management LLC, Point72 Asset Management LP, Quantbot Technologies LP, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Steadfast Capital Management LP, T. Rowe Price Associates Inc, and 3 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.